Overview of key peptide research compounds including BPC-157, CJC-1295, Ipamorelin and GHK-Cu, with focus on...
Latest posts
-
Lyophilized Peptides: Stability, Reconstitution and Common Handling MistakesRead more -
The use of KCF-18, a peptide originating from cytokine receptors, as a therapeutic approach for anti-inflammatory purposes through binding to proinflammatory cytokines.Read moreThe use of peptides derived from cytokine receptors as a therapeutic strategy for anti-inflammation has been...
Blog categories
Search in blog
Archived posts
Latest posts
- Lyophilized Peptides: Stability, Reconstitution and Common Handling MistakesRead more
Overview of key peptide research compounds including BPC-157, CJC-1295, Ipamorelin and GHK-Cu, with focus on laboratory use and technical characteristics.
- The use of KCF-18, a peptide originating from cytokine receptors, as a therapeutic approach for anti-inflammatory purposes through binding to proinflammatory cytokines.Read more
The use of peptides derived from cytokine receptors as a therapeutic strategy for anti-inflammation has been investigated. These peptides are designed to specifically bind proinflammatory cytokines, providing a potential means of regulating immune responses. Through this mechanism, the peptides may serve as a valuable tool in the development of novel immunomodulatory agents.
Showing 1 to 2 of 2 (1 Pages)